5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Low arterial oxygen partial pressure induces pulmonary thrombocytopenia in patients and a mouse model

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Recent basic studies demonstrate that the lung is a primary organ of platelet biogenesis. However, whether the pathophysiological state of the lung affect the platelets is little known. We aim to investigate the incidence of thrombocytopenia in patients with pulmonary infection (PIN) and risk factors associated with pulmonary thrombocytopenia.

          Methods

          In total, 11,941 patients with pulmonary infection (PIN) were enrolled, and patients with other three infectious diseases were collected as controls. The incidence of thrombocytopenia was compared, and the risk factors associated with thrombocytopenia in PIN patients were investigated by multivariate analysis. To explore the mechanism of thrombocytopenia, hypoxic model was constructed. Blood platelet counts from the angular vein (PLTs), left ventricle (PLT post) and right ventricle (PLT pre) were determined. Megakaryocytes identified by anti-CD41 antibody were detected through flow cytometry and immunofluorescence.

          Results

          The incidence of thrombocytopenia in PIN was higher than that in other three infectious diseases (9.8% vs. 6.4% ~ 5.0%, P < 0.001). Low arterial oxygen partial pressure (PaO 2) was an important risk factor for thrombocytopenia (OR = 0.88; P < 0.001). In a hypoxic mouse model, PLTs decreased (518.38 ± 127.92 vs 840.75 ± 77.30, P < 0.05), which showed that low PaO 2 induced thrombocytopenia. The difference between the PLT post and PLT pre (∆PLT post-pre), representing the production of platelets in the lungs, was significantly attenuated in hypoxic mice when compared with normoxic mice (F = 25.47, P < 0.05). Additionally, proportions of CD41-positive megakaryocytes in the lungs, marrow, spleen all decreased in hypoxic mice.

          Conclusion

          There is a high incidence for thrombocytopenia in PIN patients. Low PaO 2-induced thrombocytopenia is associated with impaired generation of platelet in the lungs.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          APACHE II: a severity of disease classification system.

          This paper presents the form and validation results of APACHE II, a severity of disease classification system. APACHE II uses a point score based upon initial values of 12 routine physiologic measurements, age, and previous health status to provide a general measure of severity of disease. An increasing score (range 0 to 71) was closely correlated with the subsequent risk of hospital death for 5815 intensive care admissions from 13 hospitals. This relationship was also found for many common diseases. When APACHE II scores are combined with an accurate description of disease, they can prognostically stratify acutely ill patients and assist investigators comparing the success of new or differing forms of therapy. This scoring index can be used to evaluate the use of hospital resources and compare the efficacy of intensive care in different hospitals or over time.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The lung is a site of platelet biogenesis and a reservoir for hematopoietic progenitors

            Platelets are critical for hemostasis, thrombosis, and inflammatory responses 1,2 , yet the events leading to mature platelet production remain incompletely understood 3 . The bone marrow (BM) is proposed to be a major site of platelet production although indirect evidence points towards a potential pulmonary contribution to platelet biogenesis 4-7 . By directly imaging the lung microcirculation in mice 8 , we discovered that a large number of megakaryocytes (MKs) circulate through the lungs where they dynamically release platelets. MKs releasing platelets in the lung are of extrapulmonary origin, such as the BM, where we observed large MKs migrating out of the BM space. The lung contribution to platelet biogenesis is substantial with approximately 50% of total platelet production or 10 million platelets per hour. Furthermore, we identified populations of mature and immature MKs along with hematopoietic progenitors that reside in the extravascular spaces of the lung. Under conditions of thrombocytopenia and relative stem cell deficiency in the BM 9 , these progenitors can migrate out of the lung, repopulate the BM, completely reconstitute blood platelet counts, and contribute to multiple hematopoietic lineages. These results position the lung as a primary site of terminal platelet production and an organ with considerable hematopoietic potential.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The incredible journey: From megakaryocyte development to platelet formation

              Circulating blood platelets are specialized cells that prevent bleeding and minimize blood vessel injury. Large progenitor cells in the bone marrow called megakaryocytes (MKs) are the source of platelets. MKs release platelets through a series of fascinating cell biological events. During maturation, they become polyploid and accumulate massive amounts of protein and membrane. Then, in a cytoskeletal-driven process, they extend long branching processes, designated proplatelets, into sinusoidal blood vessels where they undergo fission to release platelets. Given the need for platelets in many pathological situations, understanding how this process occurs is an active area of research with important clinical applications.
                Bookmark

                Author and article information

                Contributors
                hongkui88@163.com
                Journal
                BMC Pulm Med
                BMC Pulm Med
                BMC Pulmonary Medicine
                BioMed Central (London )
                1471-2466
                6 January 2021
                6 January 2021
                2021
                : 21
                : 3
                Affiliations
                [1 ]GRID grid.412455.3, Department of Cardiovascular Medicine and Jiangxi Key Laboratory of Molecular Medicine, , The Second Affiliated Hospital of Nanchang University, ; Nanchang, 330006 Jiangxi China
                [2 ]GRID grid.412455.3, Department of Hematology Medicine, , The Second Affiliated Hospital of Nanchang University, ; Nanchang, China
                [3 ]GRID grid.412455.3, Molecular Medicine of Jiangxi Key Laboratory, , The Second Affiliated Hospital of Nanchang University, ; Nanchang, China
                [4 ]GRID grid.412455.3, Department of Respiratory Medicine, , The Second Affiliated Hospital of Nanchang University, ; Nanchang, China
                [5 ]GRID grid.412455.3, Department of Genetic Medicine, , The Second Affiliated Hospital of Nanchang University, ; Nanchang, China
                Author information
                http://orcid.org/0000-0001-9416-0862
                Article
                1381
                10.1186/s12890-020-01381-7
                7789170
                33407285
                3af21e8a-dae9-4b81-9e80-70c882c4dcd2
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 13 June 2020
                : 15 December 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81530013
                Award ID: 81600243
                Award Recipient :
                Funded by: National Key R&D Program of China
                Award ID: 2017YFC1307804
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2021

                Respiratory medicine
                pulmonary infection,thrombocytopenia,lung,platelet,oxygen partial pressure
                Respiratory medicine
                pulmonary infection, thrombocytopenia, lung, platelet, oxygen partial pressure

                Comments

                Comment on this article